Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

VectivBio AG
Sponsor

VectivBio AG

Aeschenvorstadt 36, 4051

About the sponsor

Research activity includes acute graft versus host disease, with a focus on steroid-refractory gastrointestinal aGVHD affecting the lower digestive tract.

  • Immune-mediated intestinal injury
  • Gastrointestinal inflammation
  • Post-transplant complications

The sponsor’s studies in this area are centered on gastrointestinal symptoms and clinical safety in patients with severe transplant-related bowel involvement.

About Specializations

VectivBio AG runs clinical trials in conditions such as Short-bowel syndrome, Acute graft versus host disease in intestine, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Short-bowel syndrome

Not recruiting
InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Apraglutide
  • Sponsor:VectivBio AG

Acute graft versus host disease in intestine

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Apraglutide
  • Sponsor:VectivBio AG

Short-bowel syndrome

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Apraglutide
  • Sponsor:VectivBio AG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.